Roswell Park, BMS Foundation create $3.3 million program to address cancer burden for native and rural communities

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Roswell Park Comprehensive Cancer Center and the Bristol Myers Squibb Foundation have established a $3.3 million program to address the cancer burden in rural areas and Native Nations across New York State, with an emphasis on the Western New York region.

The grant from the Bristol Myers Squibb Foundation supports a service collaboration between Roswell Park, the Indian Health Service and geographically matched rural federally qualified health centers across New York.

It will allow Roswell Park to provide on-site and virtual patient navigation consisting of cancer prevention, screening, treatment and education as well as available education on clinical trials, palliative care and survivorship. The primary focus will be on breast cancer and prostate cancer and secondarily on co-occurring conditions that have high rates in these communities.

Six full-time patient navigators in the high-need communities as well as two virtual navigators will be created through the grant. The funding will support:

  • Mobilization of a network of patient navigators in collaboration with IHS health centers and adjacent FQHCs that serve Native American and rural community members to provide a tailored program to improve screening and co-occurring disease management.

  • Administration of in-person, phone-based and virtual web-based navigation systems for tribal and FQHC communities.

  • Work by patient navigators with healthcare staff and participating clinics to provide education on breast and prostate cancer screening guidelines, cancer care continuum and management of co-occurring conditions.

The initiative was designed to incorporate the Two Row Wampum philosophy developed by the Haudenosaunee and based on the Two Row Wampum Belt and the Covenant Chain of Friendship.

Historically, this Wampum agreement was used as a guideline between Native Americans and the Dutch, French, British and Canada. Like the Two Row Wampum, this patient navigation collaboration will provide a bridge between two health delivery systems that are functioning in parallel, like two boats in the same river.

“This work allows us to expand efforts with federally qualified health centers and move into more rural and remote areas, strengthening our established relationships to reshape and refocus our breast and prostate cancer screening,” Kate Glaser, assistant professor of oncology in Roswell Park’s Department of Cancer Prevention and Control, said in a statement. “With limited navigation in IHS sites or rural health centers focused on addressing cancer disparities, this service is providing a unique opportunity to improve cancer screening and cancer care in this population.”

“The initiative does align with the IHS vision of healthy communities and quality health care systems through strong partnerships and culturally responsive practices by creating a Native American patient navigator team focusing on breast and prostate cancer and co-occurring conditions,” Rear Admiral Michael Toedt, chief medical officer of the Indian Health Service, said in a statement.

The grant will serve residents in Erie, Chautauqua, Cattaraugus, Allegheny, Niagara and Oneida counties and further north into the St. Regis Mohawk territory, Tuscarora and Tonawanda Band of Senecas through Indian Health Services–Lockport, as well as the Allegany and Cattaraugus Territories of the Seneca Nation. Recruitment for the navigator positions is underway in partnership with tribal partners, IHS clinics, IHS regional offices and our partnering FQHCs to ensure that the hiring reflects the unique perspectives of the area.

Over the three-year project, it is expected that 3,200 community members will be engaged and educated.

In This Issue


President Joe Biden’s proposed Advanced Research Projects Agency-Health would be a welcome partner to NCI—particularly in conducting large, collaborative clinical investigations, NCI Director Ned Sharpless said.“I think having ARPA-H as part of the NIH is good for the NCI,” Sharpless said April 11 in his remarks at the annual meeting of the American Association for Cancer Research. “How this would fit with the ongoing efforts in cancer at the NCI is still something to work out.”